Science Hackathon: Identifying new ways to treat eczema
APPLY NOW TO THE SCIENCE HACKATHON
Using machine learning to drive innovation in drug development:
Winning team will be awarded 5,000 euro
LEO Pharma and Iris.ai warmly welcome you to apply to the Scithon. It’s a 2-day research sprint where teams of 3-4 map out potential avenues for new targeted treatments for eczema. During the sprint you’ll get access to Iris, the AI research assistant and other research tools. Don’t have a team? No worries, you can also apply as an individual in which case we will find team members for you.
Atopic dermatitis (or eczema) is a chronic, relapsing skin disease affecting up to 30% of children in industrialised countries. The characteristic symptom is the itchy, dry skin lesions which are almost impossible to relieve. Atopic dermatitis is a heterogeneous disorder caused by a complex interplay between genetics and environmental triggers. There is a huge unmet need for new targeted treatments in atopic dermatitis to help patients who are suffering from the disease.
WHAT: Scithon is a 2-day research sprint where teams of 3-4 will explore academic literature and map out potential solutions to atopic dermatitis using artificial intelligence. All teams will have access to Iris.ai, and other research tools, during the sprint. The winning team will be selected by a panel of judges and awarded a prize of 5,000 euro.
GOAL: To identify new targets and pathways for treating atopic dermatitis.
WHEN/WHERE: 9:00am 23rd November 2017 until 6:00pm 24th November 2017 in Copenhagen, Denmark. The venue will be DARE2mansion (http://dare2mansion.com/en/home/), at Vermundsgade 13-15, 2100 København Ø. Participants are expected to work on-site throughout the sprint.
WHO WE ARE LOOKING FOR: Researchers and students from across research disciplines with a curious mind. Previous experience in the areas of dermatology, immunology or inflammation are not required but might be an advantage.
HOW TO APPLY: Apply to the Scithon by filling out this form (as team or individually). Clicking "attending" on Eventbrite won't secure you a spot). Deadline for the applications is November 12th 2017.
IPR, i.e. who owns the results after the event: The targets, pathways and related results generated in the Scithon will be owned by LEO Pharma, who is funding this research activity. LEO will independently be able to use all targets, pathways and results for further research.
Healthcare professionals: If you are a healthcare professional, you are subject to special rules and regulations on cooperation with pharmaceutical companies, which set out requirements on e.g. transparency and disclosure. By participating in the Scithon, you acknowledge and accept that LEO Pharma may make the payment of a prize conditional upon you consenting to LEO Pharma disclosing the nature of the cooperation and the prize amount.
The event is organised by Iris AI and LEO Pharma.